Aggregator
Nate Bargatze’s ‘Breadwinner’ Movie Comes to Digital, But When Will ‘The Breadwinner’ Be Streaming on Netflix?
2026 Home Run Derby prediction: MLB odds, picks, best bet for Monday
Who won ‘Love Island USA’? VRT unpacks season 8 finale
Who won ‘Love Island USA’? VRT unpacks season 8 finale
How to bet on the MLB Home Run Derby: Odds and best sportsbooks to use
Jax Taylor cozies up to his and ex Brittany Cartwright’s longtime publicist
Jax Taylor cozies up to his and ex Brittany Cartwright’s longtime publicist in steamy vacation snaps
Popular fast food chain to open 60 new restaurants, with focus on California
Mets Nailed The 2026 MLB Draft | Presented By Your Local Ford Dealers
Nicole Kidman puts a suited spin on tennis whites at Wimbledon 2026
Nicole Kidman puts a suited spin on tennis whites at Wimbledon 2026
Appeals Court Revives Tylenol Autism Lawsuits Against Kenvue
A federal appeals court has breathed new life into litigation accusing Kenvue of failing to disclose alleged risks tied to taking Tylenol during pregnancy, reversing an earlier ruling that had effectively stopped hundreds of cases, according to a new report from Bloomberg.
On Monday, the 2nd U.S. Circuit Court of Appeals concluded that the trial judge went too far in throwing out testimony from three expert witnesses. The panel said the experts relied on recognized scientific approaches and that disagreements over how to interpret the available research should be weighed through the legal process rather than dismissed outright. The lawsuits will now return to the lower court.
The decision overturns a 2023 ruling that prevented roughly 500 claims from moving forward against Kenvue, the consumer health business that was spun off from Johnson & Johnson. Bloomberg Intelligence has previously estimated that the company could ultimately face thousands of similar lawsuits, creating the potential for billions of dollars in legal exposure.
Bloomberg notes that attorneys representing the plaintiffs said the appeals court recognized that their experts relied on legitimate scientific evidence. Kenvue countered that the ruling was procedural, not a finding that Tylenol causes autism or ADHD. The company continues to argue that the best available independent research has not established a causal relationship between prenatal acetaminophen use and neurodevelopmental disorders.
Recall back in September we noted when President Donald Trump advised pregnant women to avoid Tylenol, bringing renewed public attention to a debate that has divided researchers.Even so, many medical experts and large reviews of existing studies continue to say the evidence does not demonstrate that acetaminophen use during pregnancy causes autism, ADHD, or similar developmental conditions.
"With Tylenol, don't take it, don't take it," Trump said last year, adding that the FDA would issue a notice to physicians over the risk of acetaminophen during pregnancy, and begin the process to make a safety label change. "I think we've found an answer to autism."
In October, we noted that in a Feb. 8, 2018, email obtained by The Epoch Times, Rachel Weinstein, director of epidemiology at Johnson & Johnson subsidiary Janssen, wrote, “The weight of evidence is starting to feel heavy to me.”
Weinstein was emailing Jesse Berlin, Johnson & Johnson’s global head of epidemiology, about a review that concluded that nine studies suggested that use of acetaminophen—the active ingredient in Tylenol—by pregnant women was linked to autism and other neurodevelopmental issues in the women’s children.
The legal battle is unfolding while Kimberly-Clark works to complete its planned $40 billion purchase of Kenvue. The company has said it reviewed the potential litigation risks before agreeing to the acquisition.
Tyler Durden Mon, 07/13/2026 - 15:45Shell-shocked Senate gavels in for the first time after death of chamber’s giant, Lindsey Graham
Sen. Lindsey Graham’s passing: Letters to the Editor — July 14, 2026
US Energy Efficiency: We Have Come A Long Way
The graph below paints a very interesting picture of US energy efficiency and a key structural economic change in this country.
For roughly 25 years after WWII, the US economy’s crude oil consumption nearly tripled. Feeding the growth were a booming post-war economy and strong population growth.
To put consumption in a different context, the graph shows consumption as a ratio to a dollar of real GDP, on a per capita basis.
It shows that consumption per dollar of GDP declined rapidly starting in the mid-1970s, suggesting an increase in US energy efficiency.
The US per capita energy efficiency is less pronounced but noticeable.
In addition to productivity gains and urbanization, there are a few reasons for the gains in efficiency.
-
The 1973 Arab oil embargo was a shock to the economy. During this time, a quadrupling of gas prices and long gas lines forced policymakers and consumers to treat oil as a strategic vulnerability rather than a cheap given.
-
Washington enacted numerous measures in response to persistently high oil prices in the 1970s. For instance, the Energy Policy and Conservation Act of 1975 mandated US energy efficiency standards for appliances and introduced fuel-economy standards. Legislators also encouraged a shift from oil and natural gas to coal for power generation. Utilities largely stopped building oil-fired plants.
-
Structural change was equally important. The economy shifted from heavy manufacturing to services and technology, sectors that require far less energy per dollar of output.
Ironically, AI data centers are now driving a renewed focus on efficiency, this time with natural gas and renewables.
Tyler Durden Mon, 07/13/2026 - 15:25